CA3231436A1 - Transmission de donnees d'analyte a l'aide d'ensembles d'instructions de faible puissance - Google Patents
Transmission de donnees d'analyte a l'aide d'ensembles d'instructions de faible puissance Download PDFInfo
- Publication number
- CA3231436A1 CA3231436A1 CA3231436A CA3231436A CA3231436A1 CA 3231436 A1 CA3231436 A1 CA 3231436A1 CA 3231436 A CA3231436 A CA 3231436A CA 3231436 A CA3231436 A CA 3231436A CA 3231436 A1 CA3231436 A1 CA 3231436A1
- Authority
- CA
- Canada
- Prior art keywords
- data
- analyte
- sensor
- monitoring device
- sensor data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 836
- 238000004891 communication Methods 0.000 claims abstract description 499
- 230000006854 communication Effects 0.000 claims abstract description 497
- 238000012806 monitoring device Methods 0.000 claims abstract description 187
- 210000001124 body fluid Anatomy 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims description 132
- 230000015654 memory Effects 0.000 claims description 73
- 238000012544 monitoring process Methods 0.000 claims description 52
- 230000005540 biological transmission Effects 0.000 claims description 32
- 238000003860 storage Methods 0.000 claims description 25
- 230000004913 activation Effects 0.000 claims description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 18
- 239000008103 glucose Substances 0.000 claims description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 17
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 239000001301 oxygen Substances 0.000 claims description 17
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 16
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000013507 mapping Methods 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 8
- 108010082126 Alanine transaminase Proteins 0.000 claims description 8
- 102000009027 Albumins Human genes 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 8
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 8
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 8
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 102000001554 Hemoglobins Human genes 0.000 claims description 8
- 108010054147 Hemoglobins Proteins 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 8
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 8
- 239000001569 carbon dioxide Substances 0.000 claims description 8
- 229940109239 creatinine Drugs 0.000 claims description 8
- -1 hematocrit Chemical compound 0.000 claims description 8
- 238000005534 hematocrit Methods 0.000 claims description 8
- 150000002576 ketones Chemical class 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229940116269 uric acid Drugs 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 6
- 230000036772 blood pressure Effects 0.000 claims description 5
- 230000006855 networking Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 208000033748 Device issues Diseases 0.000 abstract 1
- 230000008569 process Effects 0.000 description 61
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 28
- 230000004044 response Effects 0.000 description 25
- 230000006870 function Effects 0.000 description 23
- 230000009471 action Effects 0.000 description 20
- 238000012545 processing Methods 0.000 description 20
- 230000002093 peripheral effect Effects 0.000 description 18
- 239000003814 drug Substances 0.000 description 17
- 102000004877 Insulin Human genes 0.000 description 14
- 108090001061 Insulin Proteins 0.000 description 14
- 230000008901 benefit Effects 0.000 description 14
- 229940125396 insulin Drugs 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- 238000010586 diagram Methods 0.000 description 11
- 230000006399 behavior Effects 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000007175 bidirectional communication Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 238000012913 prioritisation Methods 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000009118 appropriate response Effects 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910000078 germane Inorganic materials 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L67/00—Network arrangements or protocols for supporting network services or applications
- H04L67/01—Protocols
- H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/80—Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0209—Operational features of power management adapted for power saving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/029—Operational features adapted for auto-initiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Signal Processing (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Computing Systems (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Des modes de réalisation de la présente invention comprennent un dispositif de surveillance d'analyte. Le dispositif de surveillance d'analyte génère des données de capteur indiquant un niveau d'analyte mesuré par un capteur d'analyte positionné de manière transcutanée en contact d'un fluide corporel du sujet. Le dispositif de surveillance d'analyte initialise un module de communication à l'aide d'un ensemble d'instructions associées au balayage de publicité, l'ensemble d'instructions associées au balayage de publicité étant un sous-ensemble d'un ensemble d'instructions de démarrage de protocole de communication comprenant l'ensemble d'instructions associées au balayage de publicité et un ensemble d'instructions non associées à un balayage de publicité. Le dispositif de surveillance d'analyte émet un ou plusieurs paquets publicitaires et reçoit une demande de connexion provenant d'un dispositif de réception. Le dispositif de surveillance d'analyte achève l'initialisation du module de communication à l'aide de l'ensemble d'instructions non associées au balayage de publicité. Le dispositif de surveillance d'analyte sélectionne un sous-ensemble des données de capteur, prépare un paquet de données comprenant le sous-ensemble des données de capteur et transmet le paquet de données au dispositif de réception.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163252120P | 2021-10-04 | 2021-10-04 | |
| US63/252,120 | 2021-10-04 | ||
| US202163292953P | 2021-12-22 | 2021-12-22 | |
| US63/292,953 | 2021-12-22 | ||
| US17/581,620 US20220150308A1 (en) | 2020-07-21 | 2022-01-21 | Transmitting analyte data using low-power instruction sets |
| US17/581,620 | 2022-01-21 | ||
| PCT/US2022/028748 WO2023059374A1 (fr) | 2021-10-04 | 2022-05-11 | Transmission de données d'analyte à l'aide d'ensembles d'instructions de faible puissance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3231436A1 true CA3231436A1 (fr) | 2023-04-13 |
Family
ID=85804608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3231436A Pending CA3231436A1 (fr) | 2021-10-04 | 2022-05-11 | Transmission de donnees d'analyte a l'aide d'ensembles d'instructions de faible puissance |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4412511A1 (fr) |
| CA (1) | CA3231436A1 (fr) |
| WO (1) | WO2023059374A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170124275A1 (en) * | 2015-10-30 | 2017-05-04 | Dexcom, Inc. | Data backfilling for continuous glucose monitoring |
| JP2019537848A (ja) * | 2016-07-20 | 2019-12-26 | デックスコム・インコーポレーテッド | ブドウ糖データを無線通信するためのシステム及び方法 |
| US11471052B2 (en) * | 2019-05-29 | 2022-10-18 | Dexcom, Inc. | System and method for wireless communication of analyte data |
| US11317803B2 (en) * | 2020-07-21 | 2022-05-03 | Pacesetter, Inc. | System and method for managing Bluetooth low energy advertising |
-
2022
- 2022-05-11 WO PCT/US2022/028748 patent/WO2023059374A1/fr active Application Filing
- 2022-05-11 EP EP22726947.9A patent/EP4412511A1/fr active Pending
- 2022-05-11 CA CA3231436A patent/CA3231436A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023059374A1 (fr) | 2023-04-13 |
| EP4412511A1 (fr) | 2024-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220150308A1 (en) | Transmitting analyte data using low-power instruction sets | |
| US11019411B2 (en) | System and method for communication of analyte data | |
| US20210212132A1 (en) | System and method for communication of analyte data | |
| US8265757B2 (en) | Regulatory compliant transmission of medical data employing a patient implantable medical device and a generic network access device | |
| CN114173653A (zh) | 用于分析物数据的无线通信的系统和方法 | |
| US20230083633A1 (en) | Modular analyte connectivity system for extendible communication with different types of physiological sensors | |
| US20230096239A1 (en) | Mobile Application Updates for Analyte Data Receiving Devices | |
| US20240040348A1 (en) | Dynamic Discovery Window for Wireless Communication Between Devices | |
| US20220202290A1 (en) | Embedded systems in medical monitoring systems | |
| CA3231562A1 (fr) | Systemes, dispositifs et procedes de communication entre un capteur d'analyte et des dispositifs externes | |
| Mosenia et al. | OpSecure: A secure unidirectional optical channel for implantable medical devices | |
| US20220263904A1 (en) | Method for managing a physical layer utilized during a wireless connection with medical devices | |
| US20230027588A1 (en) | Over-the-Air Programming of Sensing Devices | |
| CA3231436A1 (fr) | Transmission de donnees d'analyte a l'aide d'ensembles d'instructions de faible puissance | |
| US20220409053A1 (en) | Medical monitoring systems with cloud communication interface | |
| US20220409052A1 (en) | Medical monitoring systems with cloud communication interface | |
| JP2024538606A (ja) | 検体データ受信デバイスのためのモバイルアプリケーション更新 | |
| CN117751412A (zh) | 感测装置的空中编程 |